Biotech Loftware and Signant Health Announce Availability of Integrated Clinical Supplies Labeling Solution October 31, 2024
Biotech BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement October 30, 2024
Biotech Changxing Island accelerates development of world-class green petrochemical industrial base October 30, 2024
Biotech Linus Health to Demonstrate How Digital Health Powers Innovation at Clinical Trials on Alzheimer’s Disease (CTAD) October 29, 2024
Biotech Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement October 29, 2024
Biotech WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development October 28, 2024
Biotech BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting October 28, 2024
Biotech IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors October 28, 2024
Biotech ADVANCED NANOTHERAPIES ANNOUNCES POSITIVE RESULTS IN ITS FIRST-IN-HUMAN TRIAL AND PLANS FOR U.S. EARLY FEASIBILITY STUDY FOR SIRPLUX™ DUO DRUG-COATED BALLOON October 27, 2024